Clinical Trial

A Single-center Study of CM313 in Patients With Pemphigus

Name: A Single-center Study of CM313 in Patients With Pemphigus — clinical trial record (NCT06904040)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

A prospective, single-center, single-arm clinical study aimed to explore the efficacy and safety of the anti-CD38 monoclonal antibody CM313 combined with low-dose glucocorticoids in patients with pemphigus.

Trial Details

NCT Number	NCT06904040
Lead Sponsor	Sichuan Provincial People's Hospital
Conditions	Pemphigus
Enrollment	20 participants
Start Date	2025-04-01
Primary Completion	2027-10-31 (estimated)
Study Completion	2028-04-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-01